izertis, S.A. (BME:IZER)
Spain · Delayed Price · Currency is EUR 8.00
0.00 (0.00%)
Oct 6, 2026, 5:26 PM CET
izertis Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 182.06 | 161.44 | 133.08 | 117.23 | 88.43 | 65.05 |
Other Revenue | - | - | - | - | - | 0.36 |
| 182.06 | 161.44 | 133.08 | 117.23 | 88.43 | 65.4 | |
Revenue Growth | 26.29% | 21.32% | 13.52% | 32.56% | 35.21% | 28.90% |
Cost of Revenue | 154.31 | 134.96 | 111.35 | 97.72 | 76.31 | 57.17 |
Gross Profit | 27.75 | 26.48 | 21.73 | 19.51 | 12.13 | 8.23 |
Selling, General & Admin | 0.03 | - | - | - | - | - |
Amortization of Goodwill & Intangibles | 11.04 | 11.04 | 9.54 | 8.27 | 5.97 | 4.14 |
Other Operating Expenses | 4.77 | 3.63 | 2.04 | 1.5 | 0.82 | 1.19 |
Operating Expenses | 16.97 | 14.67 | 11.58 | 9.78 | 6.79 | 5.33 |
Operating Income | 10.78 | 11.82 | 10.15 | 9.73 | 5.33 | 2.9 |
Interest Expense | -6.21 | -5.35 | -5.27 | -4.05 | -1.92 | -0.95 |
Interest & Investment Income | 0.43 | 0.32 | 0.3 | 0.08 | 0.08 | 0.17 |
Earnings From Equity Investments | -0.27 | -0.27 | -0.01 | -0.01 | -0.39 | -0.04 |
Currency Exchange Gain (Loss) | -0.34 | -0.27 | -0.05 | -0.17 | -0.03 | -0.06 |
Other Non Operating Income (Expenses) | - | - | - | - | - | 0.21 |
EBT Excluding Unusual Items | 4.39 | 6.24 | 5.11 | 5.58 | 3.08 | 2.22 |
Gain (Loss) on Sale of Investments | 0.43 | 0.27 | -0.01 | -0 | -0.02 | -0.03 |
Asset Writedown | 0.04 | -0 | 0.01 | 0.06 | 0.05 | 0.01 |
Other Unusual Items | - | - | - | - | 0.91 | 0.5 |
Pretax Income | 4.86 | 6.51 | 5.11 | 5.63 | 4.02 | 2.69 |
Income Tax Expense | 2.1 | 2.06 | 0.74 | 0.62 | 0.3 | 0.33 |
Earnings From Continuing Operations | 2.75 | 4.45 | 4.37 | 5.01 | 3.72 | 2.36 |
Minority Interest in Earnings | -0.8 | -0.58 | -0.09 | 0.03 | 0.11 | -0.03 |
Net Income | 1.95 | 3.87 | 4.28 | 5.04 | 3.83 | 2.33 |
Net Income to Common | 1.95 | 3.87 | 4.28 | 5.04 | 3.83 | 2.33 |
Net Income Growth | -64.09% | -9.67% | -14.97% | 31.48% | 64.21% | 78.77% |
Shares Outstanding (Basic) | 31 | 28 | 28 | 26 | 24 | 23 |
Shares Outstanding (Diluted) | 31 | 28 | 28 | 26 | 24 | 23 |
Shares Change | 9.34% | 1.68% | 7.54% | 8.59% | 4.16% | 0.60% |
EPS (Basic) | 0.06 | 0.14 | 0.16 | 0.20 | 0.16 | 0.10 |
EPS (Diluted) | 0.06 | 0.14 | 0.16 | 0.20 | 0.16 | 0.10 |
EPS Growth | -67.16% | -11.16% | -20.94% | 21.08% | 57.66% | 77.72% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 26.62 | 28.41 | 8.13 | 12.49 | 8.88 | 4.85 |
Free Cash Flow Per Share | 0.86 | 1.01 | 0.29 | 0.49 | 0.38 | 0.21 |
Gross Margin | 15.24% | 16.40% | 16.33% | 16.64% | 13.71% | 12.58% |
Operating Margin | 5.92% | 7.32% | 7.63% | 8.30% | 6.03% | 4.43% |
Profit Margin | 1.07% | 2.40% | 3.22% | 4.30% | 4.33% | 3.57% |
Free Cash Flow Margin | 14.62% | 17.60% | 6.11% | 10.66% | 10.04% | 7.41% |
EBITDA | 20.95 | 20.71 | 17.07 | 15.82 | 9.19 | 5.24 |
EBITDA Margin | 11.51% | 12.83% | 12.83% | 13.49% | 10.39% | 8.02% |
D&A For EBITDA | 10.17 | 8.89 | 6.92 | 6.09 | 3.85 | 2.34 |
EBIT | 10.78 | 11.82 | 10.15 | 9.73 | 5.33 | 2.9 |
EBIT Margin | 5.92% | 7.32% | 7.63% | 8.30% | 6.03% | 4.43% |
Effective Tax Rate | 43.32% | 31.63% | 14.50% | 11.08% | 7.39% | 12.25% |